Advertisement

Drugs as Pretreatment before Electrical Cardioversion

  • G. L. Botto
  • M. Luzi
  • A. Sagone
Conference paper

Abstract

Atrial fibrillation (AF) is the most common arrhythmia found in clinical practice [1] and is associated with a doubling of overall morbidity and mortality from cardiovascular disease compared to healthy population [2]. While electrical cardioversion (CV) is a widely used and potentially definitive treatment for AF, it is not always successful. Even when sinus rhythm (SR) is achieved, the arrhythmia often recurs. Antiarrhythmic drugs may potentially augment electrical CV efficacy, and may facilitate maintenance of SR. However, use of these agents is not without risk.

Keywords

Atrial Fibrillation Antiarrhythmic Drug Early Recurrence Chronic Atrial Fibrillation Electrical Cardioversion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. (2001) J Am Coll Cardiol 38:1266i-ixxGoogle Scholar
  2. 2.
    Kannel WB, Wolf PA (1992) Epidemiology of atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial fibrillation mechanisms and management. Raven, New York, pp 81–92Google Scholar
  3. 3.
    Mittal S, Ayati S, Stein KM et al (2000) Transthoracic cardioversion of atrial fibrillation. Comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 101:1282–1287PubMedCrossRefGoogle Scholar
  4. 4.
    Oral H, Souza JJ, Michaud GF et al (1999) Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 340:1849–1854PubMedCrossRefGoogle Scholar
  5. 5.
    Timmermans C, Rodriguez LM, Smeets JLRM et al (1998) Immediate reinitiation of atrial fibrillation following internal defibrillation. J Cardiovasc Electrophysiol 9:122–128PubMedCrossRefGoogle Scholar
  6. 6.
    Bianconi L, Mennuni M, Lukic V et al (1996) Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol 28:700–706PubMedGoogle Scholar
  7. 7.
    Jais P, Haissaguerre M, Shah DC et al (1997) A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95:572–576PubMedCrossRefGoogle Scholar
  8. 8.
    Wijffels MCEF, Kirchhof CJHJ, Dorland R et al (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92:1954–1968PubMedCrossRefGoogle Scholar
  9. 9.
    Yu WC, Lee SH, Tai CT et al (1999) Reversal of atrial electrical remodeling following cardioversion of long standing atrial fibrillation in man. Cardiovasc Res 42:470–476PubMedCrossRefGoogle Scholar
  10. 10.
    Tieleman RG, De Langen CDJ, Van Gelder IC et al (1997) Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 95:1945–1953PubMedCrossRefGoogle Scholar
  11. 11.
    Tieleman RG, Van Gelder IC, Crijins HJGM et al (1998) Early recurrence of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 31:167–173PubMedCrossRefGoogle Scholar
  12. 12.
    De Simone A, Stabile G, Vitale DF et al (1999) Pre-treatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 34:810–814PubMedCrossRefGoogle Scholar
  13. 13.
    Botto GL, Belotti G, Ciró A et al, on behalf of the VERAF study group (2002) Verapamil in prevention of early recurrence of atrial fibrillation: final results of the VERAF study. Eur Heart J 23:660Google Scholar
  14. 14.
    Roy D, Talajic M, Dorian P et al, for the Canadian Trial of Atrial Fibrillation Investigators (2000) N Engl J Med 342:913–920PubMedCrossRefGoogle Scholar
  15. 15.
    Capucci A, Villani GQ, Aschieri D et al (2000) Oral amiodarone increases the efficacy of DC cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 21:66–73PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • G. L. Botto
    • 1
  • M. Luzi
    • 1
  • A. Sagone
    • 1
  1. 1.Department of CardiologyS. Anna HospitalComoItaly

Personalised recommendations